We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors to Assess Role of Drugs In Adverse Reactions in Trials
Sponsors to Assess Role of Drugs In Adverse Reactions in Trials
October 27, 2010
Sponsors reporting suspected unexpected serious adverse reactions (SUSARs) from clinical trials in Europe will have to include an assessment of any drug that may have played a role in the event, according to a final guidance by the European Medicines Agency (EMA).